Zimmer Biomet stock heads into the open after a 1.2 percent gain

At the close on September 18, 2026, Zimmer Biomet stock finished at USD 95.36 on the New York Stock Exchange, up 1.2 percent, with trading volume near recent averages and roughly 10.8 percent below its 52-week high ahead of an upcoming ex-dividend date.

Zimmer Biomet stock closed at USD 95.36 on the New York Stock Exchange on September 18, 2026, rising 1.2 percent from the prior session. The move left the shares about 10.8 percent below their 52-week high, with trading volume close to recent norms ahead of a late September ex-dividend date.

September 18, 2026 in numbers

Zimmer Biomet Holdings Inc. (ISIN US98956P1021) ended the session on the New York Stock Exchange at USD 95.36 on September 18, 2026, after adding 1.2 percent versus the prior close. According to a session wrap cited by Ad-hoc-news, the stock was trading about 10.8 percent below its 52-week high at that close, underscoring a moderate distance to recent peak levels. The same report noted that the shares held relatively steady in the broader context of the recent range, with intraday levels staying within a narrow band around the mid-90s USD area and volume near typical late-summer turnover.

Per that market commentary from Ad-hoc-news, attention around the stock has begun to shift toward a late September ex-dividend date, which has contributed to a relatively firm tone despite the gap to the 52-week high. In the same trading week, major United States equity benchmarks such as the S&P 500 and the Dow Jones Industrial Average showed mixed performance, with technology-heavy indices stronger and the blue-chip gauge softer, a backdrop that framed Zimmer Biomet’s modest gain as part of a selective advance across the healthcare and medical devices space.

Dividend focus today

Today, September 22, 2026, Zimmer Biomet is due to trade in the shadow of that upcoming late September ex-dividend date highlighted by Ad-hoc-news, which can influence positioning by income-focused investors ahead of the opening bell. In the broader market, recent reports such as the late-session summary from Livemint have described renewed optimism around artificial intelligence shares and easing United States Treasury yields, factors that supported major indices and could shape sentiment toward defensive growth names in healthcare today. Against that backdrop, Zimmer Biomet’s recent performance relative to its 52-week high and the approaching dividend milestone provide the key context for the stock heading into the open.